Howard Welgus, M.D., Chief Medical Officer of Arcutis
We believe roflumilast cream has the potential to be a once daily treatment that benefits patients with plaque psoriasis who currently lack suitable treatment options.
Format
JPEG
Source
Arcutis Biotherapeutics, Inc.